Results 11 to 20 of about 690,170 (210)

Managing end-stage carcinoid heart disease: A case report and literature review. [PDF]

World J Gastrointest Oncol
BACKGROUND Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are rare tumors, often diagnosed in an advanced stage when curative treatment is impossible and grueling symptoms related to vasoactive substance release by tumor cells affect patients’
Bulj N, Tomasic V, Cigrovski Berkovic M.
europepmc   +3 more sources

Late-onset multivalvular carcinoid heart disease. [PDF]

Arch Cardiol Mex
We present a 60-year-old man with an 11-year history of an ileocecal neuroendocrine tumor (NET) with a 1% proliferation index (Ki-67) and carcinoid syndrome (CS ...
Rivera K, Zielonka M, Ramírez-Martínez T, Pueyo-Balsells N, Fernández-Rodríguez D.   +4 more
europepmc   +4 more sources

Quadruple Valve Replacement for Carcinoid Heart Disease [PDF]

Brazilian Journal of Cardiovascular Surgery, 2018
Introduction: Carcinoid heart disease most frequently involves the tricuspid or, more rarely, the pulmonary valve and presents with right heart failure as 5-HT is metabolized by the lung. Left-sided valve involvement is quite rare.
Syed Saleem Mujtaba, Stephen Clark
doaj   +3 more sources

Late-stage diagnosis of carcinoid heart disease due to lack of access to health care [PDF]

Cardio-Oncology, 2023
Carcinoid syndrome (CS) is a unique constellation of symptoms caused by release of vasoactive substances from neuroendocrine tumors (Pandit et al., StatPearls, 2022).
Aditi Sharma, Maria E. Fierro, Stella Pak, Keerthi Thallapureddy, Moyosore Awobajo, Dawn Hui, Prince Otchere   +6 more
doaj   +3 more sources

Complex Tricuspid and Pulmonic Carcinoid Heart Disease With Timely Surgical Repair [PDF]

Texas Heart Institute Journal
A 63-year-old man with a history of hypertension, prediabetes, and sleep apnea presented with pedal edema, weight loss, and flushing. Laboratory work revealed elevated B-type natriuretic peptide and normocytic anemia.
John Hollowed, MD, Hawkin Woo, MD, Solomon Hamburg, MD, PhD, Abbas Ardehali, MD   +3 more
doaj   +3 more sources

Hypertension and Carcinoid Heart Disease as Initial Manifestations of Ovarian Carcinoid Tumor. [PDF]

JCEM Case Rep
Ovarian carcinoid tumors (OCTs) are rare and may cause carcinoid syndrome (CS) even in the absence of liver metastases. Carcinoid heart disease (CHD), which develops in up to 50% of patients with CS, substantially affects morbidity and mortality.
Martins Fernandes A, Reis S, Neves C, Prieto D, Aldinhas P, G Martins R.   +5 more
europepmc   +3 more sources

Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers. [PDF]

ESMO Open
Algeri L, Falkman L, Spada F, Frassoni S, Bagnardi V, Boselli S, Cardinale D, Zanobini M, Crona J, Benini L, Tamayo D, Mazzon C, Gervaso L, Cella CA, Zampino MG, Ciardiello D, Russo A, Badalamenti G, Welin S, Fazio N.   +19 more
europepmc   +3 more sources

Does Telotristat Have a Role in Preventing Carcinoid Heart Disease? [PDF]

Int J Mol Sci
Carcinoid heart disease (CHD) is a frequent and life-threatening complication in patients with carcinoid tumors. Its clinical management is challenging is some cases since serotonin-induced valve fibrosis leads to heart failure.
Herrera-Martínez AD, Fuentes-Fayos AC, Sanchez-Sanchez R, Montero AJ, Sarmento-Cabral A, Gálvez-Moreno MA, Gahete MD, Luque RM.   +7 more
europepmc   +2 more sources

Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report [PDF]

Journal of Medical Case Reports, 2018
Background Carcinoid heart disease is a frequent complication of carcinoid syndrome. It is related to the release by the carcinoid tumor and/or its metastases of bioactive substances such as serotonin.
Khadija Khay, Salim Arous, Tarik Bentaoune, Abdenasser Drighil, Rachida Habbal   +4 more
doaj   +2 more sources

Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration. [PDF]

Oncologist, 2023
Carcinoid heart disease (CaHD) is an important complication among patients with metastatic neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) eventually develop CaHD; these patients face a significantly increased risk of morbidity ...
Das S, Stockton SS, Hassan SA.
europepmc   +2 more sources